Phase I/II Study of the Combination Therapy With NC-6004 and Gemcitabine in Patients With Locally Advanced or Metastatic Pancreatic Cancer in Asian Countries.
Phase of Trial: Phase I/II
Latest Information Update: 03 Feb 2017
At a glance
- Drugs Cisplatin (Primary) ; Gemcitabine
- Indications Pancreatic cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors NanoCarrier
- 03 Aug 2012 Planned End Date changed from 1 Jun 2013 to 31 Dec 2012.
- 05 Jun 2012 Status changed from recruiting to active, no longer recruiting, according to a NanoCarrier media release.
- 05 Jun 2009 New trial record